Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · IEX Real-Time Price · USD
3.530
+0.260 (7.95%)
May 1, 2024, 4:00 PM EDT - Market closed
Myomo Revenue
In the year 2023, Myomo had annual revenue of $19.24M with 23.70% growth. Revenue in the quarter ending December 31, 2023 was $4.76M with 17.69% year-over-year growth.
Revenue (ttm)
$19.24M
Revenue Growth
+23.70%
P/S Ratio
5.23
Revenue / Employee
$190,507
Employees
101
Market Cap
100.56M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19.24M | 3.69M | 23.70% |
Dec 31, 2022 | 15.56M | 1.70M | 12.26% |
Dec 31, 2021 | 13.86M | 6.27M | 82.72% |
Dec 31, 2020 | 7.58M | 3.75M | 97.60% |
Dec 31, 2019 | 3.84M | 1.39M | 57.02% |
Dec 31, 2018 | 2.44M | 885.24K | 56.79% |
Dec 31, 2017 | 1.56M | 455.59K | 41.29% |
Dec 31, 2016 | 1.10M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PetMed Express | 276.97M |
OptiNose | 70.99M |
Allurion Technologies | 53.47M |
Elutia | 24.75M |
HOOKIPA Pharma | 20.13M |
BioXcel Therapeutics | 1.38M |
Genelux | 170.00K |
MYO News
- 8 hours ago - Myomo to Report First Quarter Financial Results on May 8, 2024 - Business Wire
- 4 weeks ago - Myomo Appoints Heather Getz to its Board of Directors - Business Wire
- 7 weeks ago - Myomo Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 2 months ago - CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro® - Business Wire
- 2 months ago - Myomo to Report Fourth Quarter Financial Results on March 7, 2024 - Business Wire
- 3 months ago - Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market - Business Wire
- 3 months ago - Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market - Business Wire
- 3 months ago - Myomo Reports Preliminary Fourth Quarter Revenue and Backlog - Business Wire